Stocktoria

CHEMED CORP CHE

NYSE · stock · Services-Home Health Care Services · website · IPO 1971-05-27 · LEI

CHEMED CORP (CHE) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.52% (safety: safe). FY2025 revenue was $2.5B at a 10.5% net margin.

Chart by TradingView
64/100
Stocktoria Quality Score · grade B
5/9
Piotroski F — financial health
9.65
Altman Z″ — distress risk · safe
0.3%
Dividend yield 5y avg · safe · Dividend payout 11.9%
-2.76
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
5 6 6 5 6 5 6 4 6 5 2016201720182019202020212022202320242025
Altman Z″
6.45 5.88 7.18 6.07 7.65 7.06 7.76 8.97 9.36 9.65 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$541.02 as of 2026-08-01 · +18.1% 1y
$377.74$541.0252-wk

Beneish M-score: -2.76 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$6.1B
P / E23.2×
Dividend yield 5y avg0.3%
Net margin 5y avg11.8%
Return on equity 5y avg30.6%
Beta0.54
Employees15,811

Analyst price target

$446.50 -17.5% vs last
consensus: buy · 4 analysts
target range $400.00 – $500.00 · median $443.00
1 buy · 3 hold
Recent analyst actions
DateFirmRating
2026-04-27RBC CapitalSector Perform (main)
2026-02-27RBC CapitalSector Perform (down)
2026-02-27OppenheimerOutperform (main)
2026-01-22JefferiesHold (down)
2025-11-10RBC CapitalOutperform (main)
2025-09-10B of A SecuritiesBuy (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Smart money · insiders, last 12 months

Insiders net sold -$847,015 on the open market · 3 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Services · percentile among 982 companies

Piotroski Fstronger than 54%
Net marginstronger than 79%
Return on equitystronger than 87%
Revenue growthstronger than 39%

Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.01
Retained earnings / assets1.921
EBIT / assets0.22
Equity / liabilities1.753

Sector peers · similar-size Services companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
CHECHEMED CORP5/99.6523.2+4.1%
AVAHAveanna Healthcare Holdings, Inc.6/9-0.468.4+20.2%
AHCOAdaptHealth Corp.5/90.26-0.5%
ADUSAddus HomeCare Corp7/95.518.9+23.2%
EDGMEdgemode, Inc.3/9
OPCHOption Care Health, Inc.5/92.9716.5+13%
BTSGBrightSpring Health Services, Inc.7/91.7871+28.2%

All Services companies →

About CHEMED CORP

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

FAQ

Is CHE financially healthy?

CHEMED CORP's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does CHE pay a dividend, and is it safe?

Yes. CHEMED CORP pays a dividend yielding about 0.52% with a 11.9% payout ratio, rated “safe” for safety.

How profitable is CHE?

In FY2025, CHEMED CORP had a net margin of 10.5% and a return on equity of 27.1%.

Is CHE overvalued or undervalued?

CHEMED CORP trades at about 29.5× trailing earnings — near its 10-year norm (10-year range 23.3×–44.5×, median 28.3×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for CHE?

The average Wall-Street price target for CHEMED CORP is $446.50, about 17.5% below the recent price, from 4 analysts (consensus: buy).

Is CHE a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on CHEMED CORP: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 23.2×, a dividend yield of 0.52%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.